Vinh Chau (@vqchau20) 's Twitter Profile
Vinh Chau

@vqchau20

ID: 1208519553120178182

calendar_today21-12-2019 22:48:24

105 Tweet

116 Followers

88 Following

Nikhil Narang, MD (@nikhil15) 's Twitter Profile Photo

Real world experience of commercial HM3 outcomes based on trial-eligibility, another tool to assist in shared decision making when considering durable MCS nicely led by laura coyle Vinh Chau

Sunil Pauwaa MD (@spauwaa) 's Twitter Profile Photo

Nikhil Narang, MD leading an excellent discussion on TTR amyloid therapies with Gene Kim at the chicago heart failure society meeting. Tafamidis, Acoramidis, silencers, the future is hopeful. Vinh Chau Mark Belkin Mark Dela Cruz.

<a href="/Nikhil15/">Nikhil Narang, MD</a> leading an excellent discussion on TTR amyloid therapies with <a href="/GeneKimMD/">Gene Kim</a> at the chicago heart failure society meeting.  Tafamidis, Acoramidis, silencers, the future is hopeful.  <a href="/VQChau20/">Vinh Chau</a> <a href="/MarkBelkinMD/">Mark Belkin</a> <a href="/MarkDLC_MD/">Mark Dela Cruz</a>.
Nikhil Narang, MD (@nikhil15) 's Twitter Profile Photo

Dr. Allison Beckett from our CV surgery team presented key aspects of optimizating patients for high risk cardiac surgery Considerations for bleeding risk, mobility, avoidance of dialysis, early liberation from mechanical ventilation and “curbside appeal”

Dr. Allison Beckett from our CV surgery team presented key aspects of optimizating patients for high risk cardiac surgery 

Considerations for bleeding risk, mobility, avoidance of dialysis, early liberation from mechanical ventilation and “curbside appeal”
Sunil Pauwaa MD (@spauwaa) 's Twitter Profile Photo

Dr Mikhail Kosiborod launches the 11th annual ACMC Heart Failure symposium discussing Cardio metabolic interventions. Likely to be the most important advancement in CV therapeutics in the coming years.Nikhil Narang, MD Gregory Macaluso Vinh Chau

Dr Mikhail Kosiborod launches the 11th annual ACMC Heart Failure symposium discussing Cardio metabolic interventions.  Likely to be the most important advancement in CV therapeutics in the coming years.<a href="/Nikhil15/">Nikhil Narang, MD</a> <a href="/gmac78/">Gregory Macaluso</a> <a href="/VQChau20/">Vinh Chau</a>
Nikhil Narang, MD (@nikhil15) 's Twitter Profile Photo

Want to know some practical tips of managing remote monitoring devices for your patients with chronic heart failure? 📎 Link to our new review in Current Opinion in Cardiology: tinyurl.com/bdh5tt6 Great teamwork with Vinh Chau

Want to know some practical tips of managing remote monitoring devices for your patients with chronic heart failure?

📎 Link to our new review in Current Opinion in Cardiology: tinyurl.com/bdh5tt6

Great teamwork with <a href="/VQChau20/">Vinh Chau</a>
Nikhil Narang, MD (@nikhil15) 's Twitter Profile Photo

Very excited to invite Jacob Abraham, MD today for our ACMC Adv HF Lecture series Topic today: Applying remote hemodynamic monitoring in chronic heart failure management

Very excited to invite <a href="/Abraham_Jacob/">Jacob Abraham, MD</a> today for our ACMC Adv HF Lecture series 

Topic today: Applying remote hemodynamic monitoring in chronic heart failure management
Gregory Macaluso (@gmac78) 's Twitter Profile Photo

Excited to recruit for our existing AHFT fellowship Advocate Health Care Christ Medical Center in Oak Lawn. ⬆️volume vad and tx program! Accepting applicants. Come join myself and Sunil Pauwaa MD Nikhil Narang, MD Vinh Chau Jess Pillarella Mark Dela Cruz and many more! ACGME ID code 1591614048

Excited to recruit for our existing AHFT fellowship <a href="/advocatehealth/">Advocate Health Care</a> Christ Medical Center in Oak Lawn. ⬆️volume vad and tx program! Accepting applicants. 
Come join myself and <a href="/SPauwaa/">Sunil Pauwaa MD</a> <a href="/Nikhil15/">Nikhil Narang, MD</a> <a href="/VQChau20/">Vinh Chau</a> <a href="/DrJessP_MD/">Jess Pillarella</a> <a href="/MarkDLC_MD/">Mark Dela Cruz</a> and many more! 
ACGME ID code 1591614048
Nikhil Narang, MD (@nikhil15) 's Twitter Profile Photo

When using IABP for HF-Cardiogenic Shock, what is the hemodynamic response stratified by PAPi (RV fxn)? ✅ No change in Cardiac Index w/ PAPi < 2 over 72 hr ✅ ⬆️ diuretics + vasopressor/inotropes in PAPi< 2 💥 Our work now in European Society of Cardiology Journals #ESCHF 📎 tinyurl.com/35rkxzuw

When using IABP for HF-Cardiogenic Shock, what is the hemodynamic response stratified by PAPi (RV fxn)?

✅ No change in Cardiac Index w/ PAPi &lt; 2 over 72 hr

✅ ⬆️  diuretics + vasopressor/inotropes in PAPi&lt; 2

💥 Our work now in <a href="/ESC_Journals/">European Society of Cardiology Journals</a> #ESCHF 

📎 tinyurl.com/35rkxzuw
Nikhil Narang, MD (@nikhil15) 's Twitter Profile Photo

Phenomenal resources on HF-CS IABP l HF-CS Justin Fried pubmed.ncbi.nlm.nih.gov/29678608/ RHC Mastery: onlinejcf.com/article/S1071-… Jon Grinstein MD Mark Belkin RV CS in CSWG Navin Kapur Manreet Kanwar onlinejcf.com/article/S1071-… CS phenotyping tinyurl.com/muw4s2w2 Shashank Sinha, MD, MSc, FACC, FAHA, FHFSA

Nikhil Narang, MD (@nikhil15) 's Twitter Profile Photo

So thrilled to have our friend Jonathan Menachem join us today for our ACMC Advanced HF Lecture series, a little education today despite the cancellation of HFSA ASM

So thrilled to have our friend <a href="/menachem_j/">Jonathan Menachem</a> join us today for our ACMC Advanced HF Lecture series, a little education today despite the cancellation of <a href="/HFSA/">HFSA</a> ASM
Nikhil Narang, MD (@nikhil15) 's Twitter Profile Photo

What is the burden of VAD related AE’s in pts w/ HM3 VAD w/ and w/out temp RVAD? At 1-Yr: ⬆️ mortality ⬆️ risk of dialysis ⬆️ stroke (propensity matched) 🟰 risk GIB, infection, VT Our large Advocate experience now in ESC Heart Failure Journal 📎 onlinelibrary.wiley.com/doi/10.1002/eh…

What is the burden of VAD related AE’s in pts w/ HM3 VAD w/ and w/out temp RVAD?

At 1-Yr:
⬆️ mortality 
⬆️ risk of dialysis 
⬆️ stroke (propensity matched) 
🟰 risk GIB, infection, VT

Our large Advocate experience now in <a href="/ESCHeartFailure/">ESC Heart Failure Journal</a> 

📎 onlinelibrary.wiley.com/doi/10.1002/eh…